Crane / Loghavi

Precision Molecular Pathology of Aggressive B-Cell Lymphomas

Springer Nature Switzerland

ISBN 978-3-031-46842-1

Standardpreis


139,09 €

sofort lieferbar!

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

auch verfügbar als Buch (Hardcover) für 213,99 €

Bibliografische Daten

eBook. PDF. Weiches DRM (Wasserzeichen)

2024

XVII, 438 p. 88 illus. in color..

In englischer Sprache

Umfang: 438 S.

Verlag: Springer Nature Switzerland

ISBN: 978-3-031-46842-1

Weiterführende bibliografische Daten

Das Werk ist Teil der Reihe: Molecular Pathology Library

auch verfügbar als Buch (Hardcover) für 213,99 €

Produktbeschreibung

Written by experts in the field, Precision Molecular Pathology of Aggressive B-Cell Lymphomas contains the most recent revisions from the 5th Edition WHO and 2022 International Consensus Classification diagnostic categories and serves as an important resource for trainees, pathologists, haematologist/oncologists, other clinicians involved in lymphoma care and lymphoma researchers. It provides a comprehensive yet concise synthesis of emerging molecular advances that inform patient care and improve understanding of disease mechanisms. In addition, it provides the necessary background to how molecular techniques are performed to enable the reader to better interpret and critically evaluate relevant and emerging data.
As part of the Molecular Pathology Library series, this book focuses specifically on aggressive B-cell lymphomas given the increasing relevance of molecular data for diagnosis and treatment of these disorders. This evidence-based text contains 25 chapters and is divided into 5 parts. Part 1 provides a brief history and background of aggressive B-cell lymphomas. Landmark events in their classification and treatment are given in order to place the substantial advances in the field in context. Part 2 reviews molecular pathology methods, including the increasing use of next generation sequencing techniques in clinical practice. Parts 3 and 4 focus on individual subtypes of aggressive B-cell lymphoma, including a summary of the diagnostic criteria and key pathologic and clinical features for each entity. Finally, Part 5 focuses on emerging molecular technologies that may significantly impact clinical practice.

Autorinnen und Autoren

Produktsicherheit

Hersteller

Springer-Verlag GmbH

Tiergartenstr. 17
69121 Heidelberg, DE

ProductSafety@springernature.com

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Rezensionen

Dieses Set enthält folgende Produkte:
    Auch in folgendem Set erhältlich:

    • nach oben

      Ihre Daten werden geladen ...